Vascular Solutions, an Ireland-based medical device company that focuses on developing clinical solutions for coronary and peripheral vascular procedures including Guardian hemostasis valves, has acquired the assets of Zerusa, foe EUR3.15m ($4.3m).
The Guardian hemostasis valves are designed to maintain hemostasis during interventional catheterization procedures through a sealing system which allows simple introduction and removal of interventional devices while providing the option to lock guidewires in place.
Vascular Solutions has been selling the Guardian hemostasis valves in the US under an exclusive distribution relationship with Zerusa since 2007.
Effective immediately, international sales of the Guardian products will transition to Vascular Solutions’ existing international distribution network, while US sales will continue to be made through Vascular Solutions’ direct sales force.
Vascular Solutions has organized a wholly-owned subsidiary located in Galway, Ireland, to effectuate the acquisition.